TOR, the Target of Rapamycin, is now known to be a central controller of cell, tissue and organism growth and an important molecule in many human diseases including cancer, cardiac hypertrophy, diabetes and obesity. Michael Hall explains how the fortuitous decision, in 1991, to investigate the action of rapamycin in yeast led to the discovery of TOR.
View the full talk with additional resources on our website
The Story of TOR (Target of Rapamycin)
Michael Hall describes the discovery of TOR (Target of Rapamycin) protein, the key controller of the size of both individual cells and entire organisms. (Talk recorded in February 2017)
Audience:
- Student
- Researcher
- Educators of H. School / Intro Undergrad
- Educators of Adv. Undergrad / Grad
Duration: 00:24:39